Health Trials

Histiocytic Disorder Follow-up Study

ConditionsHistiocytosisLangerhans Cell HistiocytosisErdheim-Chester DiseaseRosai Dorfman DiseaseXanthogranulomaMalignant Histiocytoses
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-89
SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of the study is to describe the burden of chronic health conditions, psychological dysfunction, chronic pain, healthcare utilization, worse health-related quality of life, overall mortality, and cause-specific mortality among individuals with histiocytic disorders

Eligibility criteria

Qualifiers

diagnosis of histiocytic disorder at any age

Langerhans cell histiocytosis,

Erdheim-Chester disease,

Rosai-Dorfman disease,

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University of Alabama at Birmingham

Lead sponsor

Source ClinicalTrials.gov